Subterfuge and sabotage: Evasion of host innate defenses by invasive gram-positive bacterial pathogens

Annual Review of Microbiology

Volumn 68, Issue , 2014, Pages 439-458

  Okumura, Cheryl Y M ^a   Nizet, Victor ^b  

^a OCCIDENTAL COLLEGE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Immune evasion; Innate immunity; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes

Indexed keywords

CYTOLYSIN; PATTERN RECOGNITION RECEPTOR; POLYPEPTIDE ANTIBIOTIC AGENT; REACTIVE OXYGEN METABOLITE; VIRULENCE FACTOR;

BACTERIAL IMMUNITY; CELL ACTIVATION; CELL DEATH; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; GRAM POSITIVE BACTERIUM; IMMUNE EVASION; INNATE IMMUNITY; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; RESPIRATORY BURST; REVIEW; ANIMAL; GENETICS; GRAM POSITIVE INFECTION; HUMAN; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; VIRULENCE;

ANIMALS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; VIRULENCE;

EID: 84907514896     PISSN: 00664227     EISSN: 15453251     Source Type: Book Series    
DOI: 10.1146/annurev-micro-092412-155711     Document Type: Review

References (138)

1. Agarwal V, Ahl J, Riesbeck K, Blom AM. 2013. An alternative role of C1q in bacterial infections: facilitating Streptococcus pneumoniae adherence and invasion of host cells. J. Immunol. 191:4235-45
2. AgarwalV,Hammerschmidt S, Malm S, Bergmann S, Riesbeck K, Blom AM. 2012. Enolase of Streptococcus pneumoniae binds human complement inhibitor C4b-binding protein and contributes to complement evasion. J. Immunol. 189:3575-84
3. Agarwal V, Kuchipudi A, Fulde M, Riesbeck K, Bergmann S, Blom AM. 2013. Streptococcus pneumoniae endopeptidase O (PepO) is a multifunctional plasminogen- and fibronectin-binding protein, facilitating evasion of innate immunity and invasion of host cells. J. Biol. Chem. 288:6849-63
4. Alonzo F 3rd, Kozhaya L, Rawlings SA, Reyes-Robles T, DuMont AL, et al. 2013. CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature 493:51-55
5. Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A. 2012. Neutrophil function: from mechanisms to disease. Annu. Rev. Immunol. 30:459-89
6. Anderson R, Steel HC, Cockeran R, Smith AM, von Gottberg A, et al. 2007. Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae. J. Antimicrob. Chemother. 59:224-29
7. Askariana F, van Sorge NM, Sangvika M, Beasley FC, Henriksend JR, et al. 2014. A Staphylococcus aureus TIR-domain protein virulence factor blocks TLR2-mediated NF-κB signaling. J. Innate Immun. 6:485-98
8. AtilanoML, Yates J, GlittenbergM, Filipe SR, Ligoxygakis P. 2011. Wall teichoic acids of Staphylococcus aureus limit recognition by the Drosophila peptidoglycan recognition protein-SA to promote pathogenicity. PLoS Pathog. 7:e1002421
9. Balaban N, Cirioni O, Giacometti A, Ghiselli R, Braunstein JB, et al. 2007. Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP. Antimicrob. Agents Chemother. 51:2226-29
10. Beiter K, Wartha F, Albiger B,Normark S, Zychlinsky A,Henriques-Normark B. 2006. An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps. Curr. Biol. 16:401-7
11. Bera A, Biswas R, Herbert S, Kulauzovic E,Weidenmaier C, et al. 2006. Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus. J. Bacteriol. 189:280-83
12. Berends ETM, Dekkers JF, Nijland R, Kuipers A, Soppe JA, et al. 2013. Distinct localization of the complement C5b-9 complex on gram-positive bacteria. Cell Microbiol. 5:1955-68
13. Berends ETM, Horswill AR, Haste NM, Monestier M, Nizet V, von Kockritz-Blickwede M. 2010. Nuclease expression by Staphylococcus aureus facilitates escape from neutrophil extracellular traps. J. Innate Immun. 2:576-86
14. Brown S, Santa Maria J, John P, Walker S. 2013. Wall teichoic acids of gram-positive bacteria. Annu. Rev. Microbiol. 67:313-36
15. Bryan JD, ShelverDW.2009. Streptococcus agalactiae CspA is a serine protease that inactivates chemokines. J. Bacteriol. 191:1847-54
16. Buchanan JT, Simpson AJ, Aziz RK, Liu GY, Kristian SA, et al. 2006. DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Curr. Biol. 16:396-400
17. Carapetis JR, Steer AC, Mulholland EK, Weber M. 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5:685-94
18. Carlin AF, Chang Y-C, Areschoug T, Lindahl G, Hurtado-Ziola N, et al. 2009. Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5. J. Exp. Med. 206:1691-99
19. Carlin AF, Lewis AL, Varki A, Nizet V. 2007. Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes. J. Bacteriol. 189:1231-37
20. Carlin AF, Uchiyama S, Chang Y-C, Lewis AL, Nizet V, Varki A. 2009. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood 113:3333-36
21. Carlsson F, Sandin C, Lindahl G. 2005. Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway. Mol. Microbiol. 56:28-39
22. Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ. 2008. The biology and future prospects of antivirulence therapies. Nat. Rev. Microbiol. 6:17-27
23. Chang YC, Olson J, Beasley FC, Tung C, Zhang J, et al. 2014. Group B Streptococcus engages an inhibitory Siglec through sialic acid mimicry to blunt innate immune and inflammatory responses in vivo. PLoS Pathog. 10:e1003846
24. Charrel-Dennis M, Latz E, Halmen KA, Trieu-Cuot P, Fitzgerald KA, et al. 2008. TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA. Cell Host Microbe 4:543-54
25. Cho JH. 2005. Human peptidoglycan recognition protein S is an effector of neutrophil-mediated innate immunity. Blood 106:2551-58
26. Chow OA, von Kockritz-Blickwede M, Bright AT, Hensler ME, Zinkernagel AS, et al. 2010. Statins enhance formation of phagocyte extracellular traps. Cell Host Microbe 8:445-54
27. Cirioni O, Giacometti A, Ghiselli R, DellAcqua G, Orlando F, et al. 2006. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. J. Infect. Dis. 193:180-86
28. Cockeran R, DurandtC, Feldman C, Mitchell TJ, AndersonR. 2002. Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro. J. Infect. Dis. 186:562-65
29. Cole JN, Pence MA, von Kockritz-Blickwede M, Hollands A, Gallo RL, et al. 2010. M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A Streptococcus. Mbio 1:e00191-10
30. Collin M, SvenssonMD, Sjoholm AG, Jensenius JC, Sjobring U, Olsen A. 2002. EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis. Infect. Immun. 70:6646-51
31. Costa A,GuptaR, Signorino G, Malara A,Cardile F, et al. 2012. Activation of theNLRP3 inflammasome by Group B streptococci. J. Immunol. 188:1953-60
32. Crisostomo MI, Vollmer W, Kharat AS, Inhulsen S, Gehre F, et al. 2006. Attenuation of penicillin resistance in a peptidoglycan O-acetyl transferase mutant of Streptococcus pneumoniae. Mol. Microbiol. 61:1497-509
33. Datta V, Myskowski SM, Kwinn LA, Chiem DN, Varki N, et al. 2005. Mutational analysis of the group A streptococcal operon encoding streptolysin S and its virulence role in invasive infection. Mol. Microbiol. 56:681-95
34. Dave S, Brooks-Walter A, Pangburn MK, McDaniel LS. 2001. PspC, a pneumococcal surface protein, binds human factor H. Infect. Immun. 69:3435-37
35. Davis KM, Nakamura S, Weiser JN. 2011. Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. J. Clin. Investig. 121:3666-76
36. Derre-Bobillot A, Cortes-Perez NG, Yamamoto Y, Kharrat P, Couve E, et al. 2013. Nuclease A (Gbs0661), an extracellular nuclease of Streptococcus agalactiae, attacks the neutrophil extracellular traps and is needed for full virulence. Mol. Microbiol. 89:518-31
37. DuMont AL, Yoong P, Surewaard BGJ, Benson MA, Nijland R, et al. 2013. Staphylococcus aureus elaborates leukocidin AB to mediate escape from within human neutrophils. Infect. Immun. 81:1830-41
38. Ermert D, Weckel A, Agarwal V, Frick IM, Bj orck L, Blom AM. 2013. Binding of complement inhibitor C4b-binding protein to a highly virulent Streptococcus pyogenes M1 strain is mediated by protein H and enhances adhesion to and invasion of endothelial cells. J. Biol. Chem. 288:32172-83
39. Escaich S. 2008. Antivirulence as a new antibacterial approach for chemotherapy. Curr. Opin. Chem. Biol. 12:400-8
40. Farshchi Andisi V, Hinojosa CA, de Jong A, Kuipers OP, Orihuela CJ, Bijlsma JJE. 2012. Pneumococcal gene complex involved in resistance to extracellular oxidative stress. Infect. Immun. 80:1037-49
41. Gallis HA, Miller SE, Wheat RW. 1976. Degradation of 14C-labeled streptococcal cell walls by egg white lysozyme and lysosomal enzymes. Infect. Immun. 13:1459-66
42. Gratz N, SillerM, Schaljo B, Pirzada ZA, Gattermeier I, et al. 2008. Group A Streptococcus activates type I interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9. J. Biol. Chem. 283:19879-87
43. GroszM, Kolter J, Paprotka K,Winkler A-C, Schäfer D, et al. 2014. Cytoplasmic replication of Staphylococcus aureus upon phagosomal escape triggered by phenol-soluble modulin α. Cell Microbiol. 16:451-65
44. Gusarov I, Shatalin K, Starodubtseva M, Nudler E. 2009. Endogenous nitric oxide protects bacteria against a wide spectrum of antibiotics. Science 325:1380-84
45. Hair PS, Echague CG, Sholl AM,Watkins JA, Geoghegan JA, et al. 2010. Clumping factor A interaction with complement factor I increases C3b cleavage on the bacterial surface of Staphylococcus aureus and decreases complement-mediated phagocytosis. Infect. Immun. 78:1717-27
46. Hakansson A, Bentley CC, Shakhnovic EA, Wessels MR. 2005. Cytolysin-dependent evasion of lysosomal killing. Proc. Natl. Acad. Sci. USA 102:5192-97
47. Henneke P, Takeuchi O, Malley R, Lien E, Ingalls RR, et al. 2002. Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways. J. Immunol. 169:3970-77
48. Hirst RA, Yesilkaya H, Clitheroe E, Rutman A, Dufty N, et al. 2002. Sensitivities of human monocytes and epithelial cells to pneumolysin are different. Infect. Immun. 70:1017-22
49. Holden JK, Li H, Jing Q, Kang S, Richo J, et al. 2013. Structural and biological studies on bacterial nitric oxide synthase inhibitors. Proc. Natl. Acad. Sci. USA 110:18127-31
50. Hollands A, Gonzalez D, Leire E, Donald C, Gallo RL, et al. 2012. A bacterial pathogen co-opts host plasmin to resist killing by cathelicidin antimicrobial peptides. J. Biol. Chem. 287:40891-97
51. Honda-Ogawa M, Ogawa T, Terao Y, Sumitomo T, Nakata M, et al. 2013. Cysteine proteinase from Streptococcus pyogenes enables evasion of innate immunity via degradation of complement factors. J. Biol. Chem. 288:15854-64
52. Hongo I, BabaT,Oishi K, Morimoto Y, ItoT,Hiramatsu K. 2009. Phenol-solublemodulin α3 enhances the human neutrophil lysis mediated by Panton-Valentine leukocidin. J. Infect. Dis. 200:715-23
53. HuCM,Fang RH, Copp J, Luk BT,Zhang L. 2013.Abiomimetic nanosponge that absorbs pore-forming toxins. Nat. Nanotechnol. 8:336-40
54. HyamsC,CamberleinE,Cohen JM, Bax K, Brown JS. 2010. The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms. Infect. Immun. 78:704-15
55. Inoshima I, Inoshima N, Wilke GA, Powers ME, Frank KM, et al. 2011. A Staphylococcus aureus poreforming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nat. Med. 17:1310-14
56. Janowiak BE. 2005. Glutathione synthesis in Streptococcus agalactiae: One protein accounts for γ-glutamylcysteine synthetase and glutathione synthetase activities. J. Biol. Chem. 280:11829-39
57. Jarva H, Hellwage J, Jokiranta TS, Lehtinen MJ, Zipfel PF, Meri S. 2004. The group B streptococcal and pneumococcal Hic proteins are structurally related immune evasion molecules that bind the complement inhibitor factor H in an analogous fashion. J. Immunol. 172:3111-18
58. Jin T, Bokarewa M, Foster T, Mitchell J, Higgins J, Tarkowski A. 2004. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J. Immunol. 172:1169-76
59. Johansson L, Thulin P, Sendi P, Hertzen E, Linder A, et al. 2008. Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans. Infect. Immun. 76:3399-404
60. Jones AL, Mertz RH, Carl DJ, Rubens CE. 2007. A streptococcal penicillin-binding protein is critical for resisting innate airway defenses in the neonatal lung. J. Immunol. 179:3196-202
61. Jongerius I, Kohl J, Pandey MK, Ruyken M, van Kessel KPM, et al. 2007. Staphylococcal complement evasion by various convertase-blocking molecules. J. Exp. Med. 204:2461-71
62. Jusko M, Potempa J, Kantyka T, Bielecka E, Miller HK, et al. 2014. Staphylococcal proteases aid in evasion of the human complement system. J. Innate Immun. 6:31-46
63. Kagawa TF, OConnell MR, Mouat P, Paoli M, OToole PW, Cooney JC. 2009. Model for substrate interactions in C5a peptidase from Streptococcus pyogenes: A 1.9 Å crystal structure of the active form of ScpA. J. Mol. Biol. 386:754-72
64. Kang M, Ko YP, Liang X, Ross CL, Liu Q, et al. 2013. Collagen-binding microbial surface components recognizing adhesivematrixmolecule (MSCRAMM)of gram-positive bacteria inhibit complement activation via the classical pathway. J. Biol. Chem. 288:20520-31
65. Kaplan A, Ma J, Kyme P, Wolf AJ, Becker CA, et al. 2012. Failure to induce IFN-β production during Staphylococcus aureus infection contributes to pathogenicity. J. Immunol. 189:4537-45
66. KaravolosMH. 2003. Role and regulation of the superoxide dismutases of Staphylococcus aureus. Microbiology 149:2749-58
67. Khodaverdian V, PeshoM, Truitt B, Bollinger L, Patel P, et al. 2013. Discovery of antivirulence agents against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 57:3645-52
68. Kim HK, Thammavongsa V, Schneewind O, Missiakas D. 2012. Recurrent infections and immune evasion strategies of Staphylococcus aureus. Curr. Opin. Microbiol. 15:92-99
69. Knapp S, Wieland CW, van t Veer C, Takeuchi O, Akira S, et al. 2004. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J. Immunol. 172:3132-38
70. Kobayashi SD, Braughton KR, Palazzolo-Ballance AM, Kennedy AD, Sampaio E, et al. 2010. Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus. J. Innate Immun. 2:560-75
71. Kobayashi SD, Braughton KR, Whitney AR, Voyich JM, Schwan TG, et al. 2003. Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc. Natl. Acad. Sci. USA 100:10948-53
72. Kretschmer D, Gleske AK, Rautenberg M, Wang R, Koberle M, et al. 2010. Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. Cell Host Microbe 7:463-73
73. Kristian SA, Datta V, Weidenmaier C, Kansal R, Fedtke I, et al. 2005. D-alanylation of teichoic acids promotes group A streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion. J. Bacteriol. 187:6719-25
74. Laarman AJ, Ruyken M, Malone CL, van Strijp JAG, Horswill AR,RooijakkersSHM.2011. Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion. J. Immunol. 186:6445-53
75. Lauth X, von Kockritz-Blickwede M, McNamara CW, Myskowski S, Zinkernagel AS, et al. 2009. M1 protein allows group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition. J. Innate Immun. 1:202-14
76. Lee J-H, Cho HS, Kim Y, Kim J-A, Banskota S, et al. 2013. Indole and 7-benzyloxyindole attenuate the virulence of Staphylococcus aureus. Appl. Microbiol. Biotechnol. 97:4543-52
77. Lei B,DeLeo FR,Hoe NP,GrahamMR, Mackie SM, et al. 2001. Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat. Med. 7:1298-305
78. Limbago B, Penumalli V, Weinrick B, Scott JR. 2000. Role of streptolysinOin a mousemodel of invasive group A streptococcal disease. Infect. Immun. 68:6384-90
79. Lin FY, Zhang Y, Hensler M, Liu YL, Chow OA, et al. 2012. Dual dehydrosqualene/squalene synthase inhibitors: leads for innate immune system-based therapeutics. ChemMedChem 7:561-64
80. Liu CI, Liu GY, Song Y, Yin F, Hensler ME, et al. 2008. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science 319:1391-94
81. Liu GY, Doran KS, Lawrence T, Turkson N, Puliti M, et al. 2004. Sword and shield: linked group B streptococcal-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense. Proc. Natl. Acad. Sci. USA 101:14491-96
82. Liu GY, Essex A, Buchanan JT, Datta V, HoffmanHM, et al. 2005. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J. Exp.Med. 202:209-15
83. Ly D, Taylor JM, Tsatsaronis JA, Monteleone MM, Skora AS, et al. 2014. Plasmin(ogen) acquisition by group A Streptococcus protects against C3b-mediated neutrophil killing. J. Innate Immun. 6:340-50
84. Maisey HC,Quach D, HenslerME, Liu GY, Gallo RL, et al. 2008. A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence. FASEB J. 22:1715-24
85. Marques MB, Kasper DL, Pangburn MK, Wessels MR. 1992. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect. Immun. 60:3986-93
86. McNeela EA, Burke A , Neill DR, Baxter C, Fernandes VE, et al. 2010. Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog. 6:e1001191
87. Miyoshi-Akiyama T, Takamatsu D, Koyanagi M, Zhao J, Imanishi K, Uchiyama T. 2005. Cytocidal effect of Streptococcus pyogenes on mouse neutrophils in vivo and the critical role of streptolysin S. J. Infect. Dis. 192:107-16
88. Moreland JG, Bailey G. 2006. Neutrophil transendothelial migration in vitro to Streptococcus pneumoniae is pneumolysin dependent. Am. J. Physiol. Lung Cell. Mol. Physiol. 290:L833-40
89. Niemann S,Kehrel BE, HeilmannC, RennemeierC, PetersG,Hammerschmidt S. 2009. Pneumococcal association to platelets is mediated by soluble fibrin and supported by thrombospondin-1. Thromb. Haemost. 102:735-42
90. Nishi H, Komatsuzawa H, Fujiwara T, McCallum N, Sugai M. 2004. Reduced content of lysylphosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus. Antimicrob. Agents Chemother. 48:4800-7
91. Nordenfelt P, Grinstein S, Bj orck L, Tapper H. 2012. V-ATPase-mediated phagosomal acidification is impaired by Streptococcus pyogenes through Mga-regulated surface proteins. Microb. Infect. 14:1319-29
92. Nordenfelt P, Waldemarson S, Linder A, Morgelin M, Karlsson C, et al. 2012. Antibody orientation at bacterial surfaces is related to invasive infection. J. Exp. Med. 209:2367-81
93. OBrien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, et al. 2009. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374:893-902
94. Okumura CYM, Anderson EL, Dohrmann S, Tran DN, Olson J, et al. 2013. IgG protease Mac/IdeS is not essential for phagocyte resistance or mouse virulence of M1T1 group A Streptococcus. Mbio 4:e00499- 13-e99-13
95. OSeaghdha M, Wessels MR. 2013. Streptolysin O and its co-toxin NAD-glycohydrolase protect group A Streptococcus from xenophagic killing. PLoS Pathog. 9:e1003394
96. Pandiripally V, Gregory E, Cue D. 2002. Acquisition of regulators of complement activation by Streptococcus pyogenes serotype M1. Infect. Immun. 70:6206-14
97. Pence MA, Rooijakkers SHM, Cogen AL, Cole JN, Hollands A, et al. 2010. Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 group A Streptococcus. J. Innate Immun. 2:587-95
98. Persson H, Vindebro R, von Pawel-Rammingen U. 2013. The streptococcal cysteine protease SpeB is not a natural immunoglobulin-cleaving enzyme. Infect. Immun. 81:2236-41
99. Peschel A. 1999. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 274:8405-10
100. Poyart C, PellegriniE,Marceau M, Baptista M, Jaubert F, et al. 2003. Attenuated virulence of Streptococcus agalactiae deficient in D-alanyl-lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells. Mol. Microbiol. 49:1615-25
101. Prat C, Bestebroer J, de Haas CJ, van Strijp JA, van Kessel KP. 2006. A new staphylococcal antiinflammatory protein that antagonizes the formyl peptide receptor-like 1. J. Immunol. 177:8017-26
102. ProkesovaL, Potuznikova B, Potempa J,Zikan J, Radl J, et al. 1992. Cleavage of human immunoglobulins by serine proteinase from Staphylococcus aureus. Immunol. Lett. 31:259-65
103. Ragle BE, Bubeck Wardenburg J. 2009. Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infect. Immun. 77:2712-18
104. Ragle BE, Karginov VA, Bubeck Wardenburg J. 2010. Prevention and treatment of Staphylococcus aureus pneumonia with a β-cyclodextrin derivative. Antimicrob. Agents Chemother. 54:298-304
105. Ray A, Cot M, Puzo G, Gilleron M, Nigou J. 2013. Bacterial cell wall macroamphiphiles: pathogen-/ microbe-associated molecular patterns detected by mammalian innate immune system. Biochimie 95:33-42
106. Rooijakkers SH, Ruyken M, Roos A, Daha MR, Presanis JS, et al. 2005. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat. Immunol. 6:920-27
107. Rooijakkers SHM, van Strijp JAG. 2007. Bacterial complement evasion. Mol. Immunol. 44:23-32
108. Rooijakkers SHM, van Wamel WJB, Ruyken M, van Kessel KPM, van Strijp JAG. 2005. Anti-opsonic properties of staphylokinase. Microb. Infect. 7:476-84
109. Rosch JW, Boyd AR,Hinojosa E, Pestina T, Hu Y, et al. 2010. Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell disease. J. Clin. Investig. 120:627-35
110. Saar-Dover R, Bitler A, Nezer R, Shmuel-Galia L, Firon A, et al. 2012. D-Alanylation of lipoteichoic acids confers resistance to cationic peptides in group B Streptococcus by increasing the cell wall density. PLoS Pathog. 8:e1002891
111. Sakoulas G, Okumura CY, ThienphrapaW, Olson J, Nonejuie P, et al. 2014. Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus. J. Mol. Med. 92:139-49
112. Saleh M, Bartual SG, Abdullah MR. 2013. Molecular architecture of Streptococcus pneumoniae surface thioredoxin-fold lipoproteins crucial for extracellular oxidative stress resistance and maintenance of virulence. EMBO Mol. Med. 12:1852-70
113. Shimada T, Park BG, Wolf AJ, Brikos C, Goodridge HS, et al. 2010. Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1secretion. Cell Host Microbe 7:38-49
114. Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, et al. 2004. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob. Agents Chemother. 48:4673-79
115. Sj ogren J, Okumura CYM, Collin M, Nizet V, Hollands A. 2011. Study of the IgG endoglycosidase EndoS in group A streptococcal phagocyte resistance and virulence. BMC Microbiol. 11:120
116. Staali L, Bauer S,Morgelin M, Bj orck L, Tapper H. 2006. Streptococcus pyogenes bacteria modulate membrane traffic in human neutrophils and selectively inhibit azurophilic granule fusion with phagosomes. Cell Microbiol. 8:690-703
117. Stafslien DK, Cleary PP. 2000. Characterization of the streptococcal C5a peptidase using a C5a-green fluorescent protein fusion protein substrate. J. Bacteriol. 182:3254-58
118. Standish AJ, Weiser JN. 2009. Human neutrophils kill Streptococcus pneumoniae via serine proteases. J. Immunol. 183:2602-9
119. Stemerding AM, Kohl J, Pandey MK, Kuipers A, Leusen JH, et al. 2013. Staphylococcus aureus formyl peptide receptor-like 1 inhibitor (FLIPr) and its homologue FLIPr-like are potent FcR antagonists that inhibit IgG-mediated effector functions. J. Immunol. 191:353-62
120. Sumby P, Barbian KD, Gardner DJ, Whitney AR, Welty DM, et al. 2005. Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc. Natl. Acad. Sci. USA 102:1679-84
121. Timmer AM, Timmer JC, PenceMA, Hsu LC, Ghochani M, et al. 2009. StreptolysinOpromotes group A Streptococcus immune evasion by accelerated macrophage apoptosis. J. Biol. Chem. 284:862-71
122. Tsou CC, Chiang-Ni C, Lin YS, Chuang WJ, Lin MT, et al. 2008. An iron-binding protein, Dpr, decreases hydrogen peroxide stress and protects Streptococcus pyogenes against multiple stresses. Infect. Immun. 76:4038-45
123. Uchiyama S, Andreoni F, Schuepbach RA, Nizet V, Zinkernagel AS. 2012. DNase Sda1 allows invasive M1T1 group A Streptococcus to prevent TLR9-dependent recognition. PLoS Pathog. 8:e1002736
124. Uhlemann AC,Otto M, Lowy FD, DeLeo FR. 2013. Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus. Infect. Genet. Evol. 21:563-74
125. van SorgeNM,Beasley FC, Gusarov I,Gonzalez DJ, vonKockritz-Blickwede M, et al. 2013. Methicillinresistant Staphylococcus aureus bacterial nitric-oxide synthase affects antibiotic sensitivity and skin abscess development. J. Biol. Chem. 288:6417-26
126. Verani JR, Schrag SJ. 2010. Group B streptococcal disease in infants: progress in prevention and continued challenges. Clin. Perinatol. 37:375-92
127. Vollmer W. 2000. The pgdA gene encodes for a peptidoglycan N-acetylglucosamine deacetylase in Streptococcus pneumoniae. J. Biol. Chem. 275:20496-501
128. von Kockritz-Blickwede M, Nizet V. 2009. Innate immunity turned inside-out: antimicrobial defense by phagocyte extracellular traps. J. Mol. Med. 87: 775-83
129. Walker MJ, Hollands A, Sanderson-Smith ML, Cole JN, Kirk JK, et al. 2007. DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat. Med. 13:981-85
130. Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, et al. 2007. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med. 13:1510-14
131. Wiles KG, Panizzi P, Kroh HK, Bock PE. 2010. Skizzle is a novel plasminogen- and plasmin-binding protein from Streptococcus agalactiae that targets proteins of human fibrinolysis to promote plasmin generation. J. Biol. Chem. 285:21153-64
132. Winterbourn CC, Kettle AJ. 2013. Redox reactions and microbial killing in the neutrophil phagosome. Antioxid. Redox Signal. 18:642-60
133. Yamaguchi M, Terao Y,Mori Y, Hamada S, Kawabata S. 2008. PfbA, a novel plasmin- and fibronectinbinding protein of Streptococcus pneumoniae, contributes to fibronectin-dependent adhesion and antiphagocytosis. J. Biol. Chem. 283:36272-79
134. Yesilkaya H, Andisi VF, Andrew PW, Bijlsma JJE. 2013. Streptococcus pneumoniae and reactive oxygen species: an unusual approach to living with radicals. Trends Microbiol. 21:187-95
135. YesilkayaH, Kadioglu A,Gingles N, Alexander JE, Mitchell TJ, Andrew PW. 2000. Role of manganesecontaining superoxide dismutase in oxidative stress and virulence of Streptococcus pneumoniae. Infect. Immun. 68:2819-26
136. Zinkernagel AS, Hruz P, Uchiyama S, von Kockritz-Blickwede M, Schuepbach RA, et al. 2012. Importance of toll-like receptor 9 in host defense against M1T1 group A Streptococcus infections. J. Innate Immun. 4:213-18
137. Zinkernagel AS, Timmer AM, Pence MA, Locke JB, Buchanan JT, et al. 2008. The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing. CellHostMicrobe 4:170-78
138. Zysk G, Bejo L, Schneider-Wald BK, Nau R, Heinz H. 2000. Induction of necrosis and apoptosis of neutrophil granulocytes by Streptococcus pneumoniae. Clin. Exp. Immunol. 122:61-66